ARTICLE | Clinical News
VEC-162: Phase II data
June 19, 2006 7:00 AM UTC
In a double-blind, placebo-controlled Phase II trial in 37 patients, VEC-162 improved overall sleep efficiency, especially in the middle third of the phase advanced sleep episode, reduced sleep latenc...